HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

FDA warns GLP-1 drugs can rarely reduce optic nerve blood flow and cause vision loss

Louis Nervegna · Nov 09, 2026 · ♥ 2 reactions · 0 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)
AI summary & key facts

Louis shares a news report that the FDA warns drugs like Ozempic and Zepbound can decrease blood flow to the optic nerve, raising vision loss risk. He notes it is rare. No study data are given.

It’s rare, but it can happen.

#glp1HD #glp1eyesHD #eyesHD #visionHD

The FDA is warning that GLP-1 drugs like Ozempic and Zepbound can decrease blood flow to the optic nerve, increasing the risk of vision loss.

← newer: Evidence is building that GLP-1 drugs may slow aging in mammolder: Dietary nitrate from leafy greens and beets boosts nitric ox →